Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
By revising the price of our innovative treatments, were trying to make best-in-class cardiometabolic care more affordable for as many people with type 2 diabetes, overweight and obesity in India as possible, said Vikrant Shrotriya, MD, Novo Nordisk India
s9, Om Heights, Unnati Park, Besa Nagpur, Maharashtra, 440037, India Report incorrect details
The GLP-1 receptors in your gut, brain, and pancreas have fully desensitized
A high ratio indicates a healthy, protected cell
Overall, the results showed a dose-response relationship between months of medication claims and weight loss
US$ 25.75
US$ 21.89
US$ 23.92
US$ 27.78
